181 related articles for article (PubMed ID: 20386058)
1. Intraclass correlation estimates for cancer screening outcomes: estimates and applications in the design of group-randomized cancer screening studies.
Hade EM; Murray DM; Pennell ML; Rhoda D; Paskett ED; Champion VL; Crabtree BF; Dietrich A; Dignan MB; Farmer M; Fenton JJ; Flocke S; Hiatt RA; Hudson SV; Mitchell M; Monahan P; Shariff-Marco S; Slone SL; Stange K; Stewart SL; Strickland PA
J Natl Cancer Inst Monogr; 2010; 2010(40):97-103. PubMed ID: 20386058
[TBL] [Abstract][Full Text] [Related]
2. Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care.
Zapka J; Taplin SH; Price RA; Cranos C; Yabroff R
J Natl Cancer Inst Monogr; 2010; 2010(40):58-71. PubMed ID: 20386054
[TBL] [Abstract][Full Text] [Related]
3. Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials.
Wu S; Crespi CM; Wong WK
Contemp Clin Trials; 2012 Sep; 33(5):869-80. PubMed ID: 22627076
[TBL] [Abstract][Full Text] [Related]
4. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
[TBL] [Abstract][Full Text] [Related]
5. Organizational factors and the cancer screening process.
Anhang Price R; Zapka J; Edwards H; Taplin SH
J Natl Cancer Inst Monogr; 2010; 2010(40):38-57. PubMed ID: 20386053
[TBL] [Abstract][Full Text] [Related]
6. Breast, cervical, and colorectal cancer screening status of a group of Turkish women.
Gulten G; Memnun S; Ayse K; Aygul A; Gulcin A
Asian Pac J Cancer Prev; 2012; 13(9):4273-9. PubMed ID: 23167327
[TBL] [Abstract][Full Text] [Related]
7. Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study.
Tuesley KM; Jordan SJ; Siskind DJ; Kendall BJ; Kisely S
Aust N Z J Psychiatry; 2019 Jun; 53(6):550-558. PubMed ID: 30501394
[TBL] [Abstract][Full Text] [Related]
8. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
9. [Methods to increase participation in cancer screening programmes].
Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
[TBL] [Abstract][Full Text] [Related]
10. Cancer screening estimates for U.S. metropolitan areas.
Nelson DE; Bolen J; Marcus S; Wells HE; Meissner H
Am J Prev Med; 2003 May; 24(4):301-9. PubMed ID: 12726867
[TBL] [Abstract][Full Text] [Related]
11. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.
Swan J; Breen N; Coates RJ; Rimer BK; Lee NC
Cancer; 2003 Mar; 97(6):1528-40. PubMed ID: 12627518
[TBL] [Abstract][Full Text] [Related]
12. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices.
Ruffin MT; Gorenflo DW; Woodman B
J Am Board Fam Pract; 2000; 13(1):1-10. PubMed ID: 10682879
[TBL] [Abstract][Full Text] [Related]
13. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
[TBL] [Abstract][Full Text] [Related]
14. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
15. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
16. Preventive practices of cancer screening in women: comparison of estimates from ISA--Capital survey and the telephone-based Surveillance of Risk and Protective Factors for Chronic Diseases (VIGITEL--São Paulo).
Segri NJ; Francisco PM; Alves MC; Barros MB; Cesar CL; Goldbaum M; Malta DC
Rev Bras Epidemiol; 2011 Sep; 14 Suppl 1():31-43. PubMed ID: 22002140
[TBL] [Abstract][Full Text] [Related]
17. Cancer screening.
Wender RC; Smith R; Harper D
Prim Care; 2002 Sep; 29(3):697-725. PubMed ID: 12529905
[TBL] [Abstract][Full Text] [Related]
18. Estimates of Intraclass Correlation Coefficients From Longitudinal Group-Randomized Trials of Adolescent HIV/STI/Pregnancy Prevention Programs.
Glassman JR; Potter SC; Baumler ER; Coyle KK
Health Educ Behav; 2015 Aug; 42(4):545-53. PubMed ID: 25626433
[TBL] [Abstract][Full Text] [Related]
19. Save your life: cancer screening is oversold. Know the tests to get--and those to skip.
Consum Rep; 2013 Mar; 78(3):28-33. PubMed ID: 23556197
[No Abstract] [Full Text] [Related]
20. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.
Lansdorp-Vogelaar I; Gulati R; Mariotto AB; Schechter CB; de Carvalho TM; Knudsen AB; van Ravesteyn NT; Heijnsdijk EA; Pabiniak C; van Ballegooijen M; Rutter CM; Kuntz KM; Feuer EJ; Etzioni R; de Koning HJ; Zauber AG; Mandelblatt JS
Ann Intern Med; 2014 Jul; 161(2):104-12. PubMed ID: 25023249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
